Clinical trial
PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving…
NCT00019565 · National Institutes of Health Clinical Center (CC), NIH · Completed
Key facts
| NCT number | NCT00019565 |
|---|---|
| Title | PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy |
| Official title | The Use of Positron Emission Tomography (PET) and Magnetic Resonance Imaging (MRI) to Assess the Effects of Anti-neoplastic Therapy on Tumor Associated Vasculature |
| Lead sponsor | National Institutes of Health Clinical Center (CC), NIH |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Procedure, Radiation |
| Interventions | magnetic resonance imaging, positron emission tomography, fludeoxyglucose F 18 |
| Enrollment | 53 |
| Start date | Oct 1, 1998 |
| Primary completion | Aug 1, 2008 |
| First posted | Jan 27, 2003 |
| Last update posted | Sep 26, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: